Data Science
The Biostatistics and Biomathematics Unit
Unit Director
Unit Staff
Research projects
Publications
Forums and conferences
Biometric Bulletin of IBS
The Information and Computerization Unit
Administration and Human Resource Management
Symposium on Clinical Trials and Measurement Error Print
 

Symposium on Clinical  Trials and Measurement Error to honor Prof. Laurence Freedman's 70th birthday

 

We celebrated Prof. Laurence Freedman's 70th birthday with a one-day scientific meeting to salute Prof. Freedman's work and immense contribution to the field of Biostatistics.

The meeting was held at Tel Hashomer on February 12th, 2018.

 

We were honored to have special guest lecturers from Israel and abroad:

  • Prof. Max Parmar, MRC and University College, London
  • Dr. Victor Kipnis, National Cancer Institute, NIH
  • Prof. Rebecca Betensky, Harvard School of Public health
  • Dr. Natasha Tasevska, College of Health Solutions, Arizona State University
  • Prof. Pamela Shaw, Perelman School of Medicine, University of Pennsylvania
  • Dr. Ofra Kalter-Leibovici, Cardiovascular Epidemiology Unit, Gertner Institute, Israel
  • Dr. Havi Murad, Biostatistics & Biomathematics Unit, Gertner Institute, Israel
  • Dr. Malka Gorfine, Statistics and Operations Research, Tel Aviv University, Israel
  • Prof. Laurence Freedman, Biostatistics & Biomathematics, Gertner Institute, Israel

 

The program focused on Clinical Trials and Measurement Error, but the topics varied widely in scope. The clinical trials presentations covered design of multi-arm multi-stage trials(Parmar), checking for fabricated results (Betensky) and the results of a trial of a disease management program for COPD and asthma (Kalter-Leibovici). The measurement error presentations covered the less well-known effects of Berkson error (Freedman), measurement error in longitudunal studies (Kipnis), studies of biomarkers for sugars intake (Tasevska), the SIMEX method (Shaw), Nonparametric adjustment for measurement error in time to event data: Application to risk prediction models (Gorfine) and interactions of error-prone variables (Murad).

 

Back